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The thra¢-membered ring of aziridine-2-carboxylic a id, which is susceptible to alining by nuclcophilcs, has been analyzed as a potential useful 
handle for the desisn of ~p¢cifi¢ irrevcrsibl~ inhibitors of ¢ysteine proteinases. For this thiol-reactiv¢ amino avid, an imino analogue of proline, 
a s~ond.order rate constant of 17.07 M-~.s -~ for inactivation of papain was determined. Thus° the aziridine moiety proved to be remarkably more 
reactive than activated ouble bonds° ¢.g. N-eth~,lmaleimide, or halides uch as,,-iodopropionic acid or chloroaoctie acid. Since it dccs not alkylate 
histidine under conditions in which quantitative alkylation occurs with N-ethyl-maleimide, it could represent an interesting reactive amino acid 
unit for the synthesis of a new class oi" irreversible inhibitors, at least in terms of specificity of the chemical reaction involved in the inactivation 
process. 
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1. INTRODUCTION 
Affinity labelling of the active-site cyst¢ine residue of 
cysteine proteinases has led to the successful design of 
irreversible inhibitors needed for clarifying the role of 
these enzymes in disease processes. Among the various 
approaches used for such purpose [1,2] the specific 
alkylation of the active.site thiol function represents a
reaction principle extensively exploited for this purpose. 
Correspondingly, a series of suitable thiol-reactive 
groups has been developed and incorporated into sub- 
strates in order to build-in enzyme specificity. Of the 
alkylating agents examined in this context the oxiran 
ring of the trans-epoxysuccinyl moiety, present in the 
natural inhibitor E-64, allowed the production of a 
series of powerful active-site-directed inhibitors [1-3]. 
The three-membered aziridine ring (Fig. !.), which is 
also known to react with nucleophiles, is structurally 
similar to oxiran, and, depending upon N- and C-sub- 
stituents, it is opened more or less rapidly and selec- 
tively by thiols [4,5]. This thiol-alkylating prol~rty of 
aziridine derivatives, however, has been exploited only 
in a limited manner for the development of thiol-specific 
reagents useful for protein modifications [6]. Among the 
known aziridine compounds, aziridine-2-earboxylic 
acid, an imino analogue of praline, can be prepared 
from suitably protected serine derivatives [7,8] and a 
priori this amino acid unit could represent an interesting 
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and highly promising reactive handle for the develop- 
ment of a new class of active-site-directe, d inhibitors of  
cysteine proteinases. 
In the present communication we report on the in- 
activation of papain, as the best known example of 
cysteine proteina~s, by aziridine-2-carboxylic acid as 
the thiol-trapping reagent without built-in enzyme spe- 
cificity. 
2. EXPERIMENTAL 
2.1. Materials 
Papain (BioChcmika, powder, 10.7 U/rag) was from Fluka; Z-GIy- 
ONp was prepared by standard procedures and r¢crystallized from 
90% aqueous ethanol. 4-(4-Nitrobcnzyl)-pyridine was purchased from 
Fluka and re.crystallized from aceton¢--cyclohcxan¢. Aziridine-2-car- 
bo~ylic acid and its amide were synth~ized following the route de- 
scribed by Nakajima et al. [7]; the analytical data of the resulting 
compound were in good agreement with the literature valu~ [8] and 
the IHNMR data were consistent with the a.~igned structure. 
2.2. En=yme assays 
Solutions of papain were prepared fr~h, daily, by in,bating the 
enzyme (10 "~ M) in 0.05 M sodium phosphate (pH 6.5), 5 mM EDTA 
with 5x10 -4 M cystein¢ for 45 min at 2.5"C. 
Assays were performed at 4.0x10 -~ M concentration f papain in the 
0.05 M phosphate buffer (pH 6.5) containing S mM EDTA 2.1×i0 "4 
M cysteine and Z-Gly-ONp (I0 "j M). The rate of the enz~natie hy- 
drolysis of the substrat¢ at 22eC was monitorcxl continuously at 400 
nm against the non-enzymic hydrolysis of the substrate induc~ by the 
pr~nce of cysteine. Substrate and inhibitor were di.~olvcd in DMF, 
the final con~ntration ofwhich was 16.6% ely. 
For the inhibition experiments papain (4.$xl0 -7 M) in 0.05 M phos- 
plate (pH 6.5), 5 mM EDTA, 2.35xl0 "4 M cystcine was pre-iaeubatcd 
with aziddine.2-carboxylic acid in the concentration range of 4.5xl0 -~ 
to 9.0z10 "s ~ at 22eC for 5--60 rain; then the substrat¢ was added and 
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the residual enzyme activity at time t was determined as described 
above. 
To confirm that irreversible inhibition of papain occurs in these 
e;q~riments, he enzyme (4,5x10 -7 M) was completely inactivated with 
aziridine-2-earboxylic acid (4.5x10 "s M for 60 min) and then subj~ted 
to gel-chromatography on Biogel P-4. The control enzyme maintained 
the activity after chromatography, whereas for the inactivated enzyme 
no activity could be recovered. 
2.3. Determination of  rate constants 
5.~perimental data of the inactivation of papain were treated ac- 
cording to the model of non-specific irreversible inhibitors, i.e. in 
terms of a hi-molecular protein modification reaction [10] using the 
programme GraFit [11]. 
3. RESULTS AND DISCUSSION 
Studies on irreversible inhibition of papain by ~-iodo- 
propionic acid [12,13] and chloroacetic acid [14] clearly 
revealed a bell-shaped, pH-dependent reaction rate of 
these thiol reagents with a maximum around pH 6.0. 
This behaviour was assigned to intraprotein electrostat- 
i c  interactions between sulfhydryl, imidazolium and 
carboxylate groups causing a remarkably increased nu- 
cleophilicity of the active-site sulfur anion. Furthermore 
from a comparison of the reaction rates of these alkylat- 
ing agents as acids and amides it was deduced that ionic 
interactions with the active site of the enzyme is re- 
markably affecting the inactivation rates of papain. 
These interactions were proposed to be responsible for 
a stereo-specific orientation of the ~-iodopropionic a id 
onto the reaction center and thus for the 103-fold higher 
second order rate constant determined for the inactiva- 
tion of papain by L(-)-~-iodopropionic a id (4.9×M -~ 
• s -~) than for the reaction of this halide derivative with 
cysteine (3.3×10 -~ M-~.s -~) at pH 7.0 and 25°C. Similar 
stabilization and orientation effects by electrostatic n- 
ten, etions were also expected to occur for the aziridine- 
2-carboxylie acid as potential alkylating agent of the 
active-site cystcine of papain. 
For measuring the inactivation potency of aziridine- 
2-¢arboxylie acid initial enzyme activities were deter- 
mined at increasing papain/aziridine-2-earboxylic ac d 
ratios (1:20 to 1:200) as a function of incubation time. 
Semi.logarithmic plots of the fractional enzyme activity 
remaining (at) against ime (t) of incubation with azi- 
ridine-2-carboxylic were found to be linear with correla- 
tion coefficients, r = 0.99, thus allowing estimates of the 
pseudo-first-order inactivation rates (/cob,) at the various 
enzyme/inhibitor ratios (Fig. 2). Evaluation of the kine- 
tic data according to Kitz and Wison [15] indicates a 
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Fig. I. Aziridine-2-earboxylic acid (A) and the oxiran moiety (B) of 
the natural inhibitor E-64. 
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Fig, 2, Inactivation of papain with az~ridine-2-carboxylie ac d at in- 
creasing enzyme/inhibitor ratios: 1:20 (t'3), i:30 (Ill), 1:50 (A), 1:100 (4) 
and 1:200 (V). 
very high dissociation constant (K~) of the enzyme-inac- 
tivator COlnplex. In fact, the kob~ were found to be a 
linear function of the inhibitor concentration (r = 0.998) 
and a second-order rate constant (k) of 17.07 M-l.s -1 
was determined for the inactivation process. The exper- 
imental data are therefore consistant with the model of 
aziridine-2-carboxylic acid representing primarily a 
non-specific irreversible inhibitor with an inactivation 
potency which is significantly superior to that of other 
thiol-trapping reagents, e.g. N-ethylmaleimide (I M-~.s -~, 
at 40°C and pH 6.0 with cathepsin B) [3], L(-)-0~- iodo- 
propionic acid (4.9 M-~.s -~ at 25°C and pH 7.0 with 
papain) [12] and chloroacetie acid (4.23 M-1.s -~ at 
30.5°C with papain) [14]. The enzyme-specificity of this 
thiol alkylating agent in presence of the large excess of 
cysteine, used as an additive in the assay medium, relies 
mainly on the different pK, values of the active site and 
cysteine thiol group and thus on their markedly differ- 
ent nucleophilicity. This was confirmed in seperate ex- 
periments where we have analyzed the reaction rate of 
aziridine-2-carboxylic acid with an excess of cysteine 
under conditions of the enzyme assay (22°C, pH 6.5) by 
colorimetric monitoring of the aziridine-2-carboxylic 
acid consumption using 4-(4-nitrobenzyl)-pyridine as 
reagent according to the method of Epstein et al. [16]. 
Within the limits of error of this assay system no 
appreciable reaction rate was observed at pH 6.5. This 
fully agrees with the low content of nucleophilic sulfur 
anion species present at this pH value (pK = 8.25 for 
cysteine at 25°C; I = 0.1) and the slow reaction rate 
reported for this system even at higher pH values [5]. In 
this context the reactivity of aziridine-2-carboxylic acid 
is similar to that of trans-epoxysuecinic acid [17]. 
It is also worthy to note that the aziridine-2-carbox- 
ylic acid amide was found to be less potent by orders of 
magnitude than the free carboxylic acid at pH 6.5. Sim- 
ilarly lowered rate constants have previously been 
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reported for the inactivation of papain by g-iodopro- 
picnic acid amide [12] and ¢hloroacetamide [18], a fact 
which ha~, been interpreted in terms of loss of elec- 
trostatic interaction between the carboxyl group of the 
thiol reagents and the active-site imidazole function. In 
view of these findings even the carboxyl group of azi. 
ridine-2-carboxylic acid should contribute to the sta- 
bilization and orientation of the alkylating agent, but 
this electrostatic nteraction is insufficient to lower the 
dissociation constant (K,) to kinetically significant val- 
ues. 
The data obtained in this first series of experiments 
support the working assumption that aziridine-2.ear- 
boxylic acid could represent a promising amino acid 
unit for the design of a new class of cysteine proteinase 
inhibitors if the three-membered ring is used as the reac- 
tive handle and incorporated into peptide structures 
suitable for substrate-type r cognition and binding by 
the various cysteine proteinases. Its main advantage 
could derive from its high thiol selectivity as compared 
to other thiol reagents which are known to alkylate 
imidazole as well as amino groups, although at lower 
rates than thiols. Conversely, N-alkylation of histidine 
derivatives by nueleophilic ring opening of aziridiae-2- 
carboxylic acid did not occur at room temperature 
under favoured conditions, e.g. in dry dimethylfor- 
mamide, where histidine compounds are quantitatively 
converted to N ~- and N~-sueeinimidyl derivatives via 
reaction with N-ethyl-maleimide [19]. 
Since the active sites of cysteine proteinases are 
known to contain, besides a highly reactive thiol group, 
a histidine residue, the development of aziridine-2-car- 
boxylic acid-containing inhibitors could become an in- 
teresting new approach at least in terms of specificity of 
the chemical reaction involved in the inactivation 
process. 
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